These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 14070377)

  • 1. RELATIONSHIP BETWEEN METABOLIC FATES AND ANTITUMOR ACTIVITIES OF THIOPURINES.
    ELION GB; CALLAHAN S; RUNDLES RW; HITCHINGS GH
    Cancer Res; 1963 Sep; 23():1207-17. PubMed ID: 14070377
    [No Abstract]   [Full Text] [Related]  

  • 2. [RESORPTION, DISTRIBUTION IN THE TISSUES AND EXCRETORY ACTIVITY AFTER ADMINISTRATION OF S35-LABELLED-BUTHIOPURINE IN MICE].
    FRANC Z; FRANCOVA V; JELINEK V
    Cesk Farm; 1963 Jun; 12():230-3. PubMed ID: 14076172
    [No Abstract]   [Full Text] [Related]  

  • 3. Purine ribonucleoside kinase activity and resistance to some analogs of adenosine.
    Bennett LL; Schnebli HP; Vail MH; Allan PW; Montgomery JA
    Mol Pharmacol; 1966 Sep; 2(5):432-43. PubMed ID: 5970690
    [No Abstract]   [Full Text] [Related]  

  • 4. Formation and significance of 6-methylthiopurine ribonucleotide as a metabolite of 6-mercaptopurine.
    Bennett LL; Allan PW
    Cancer Res; 1971 Feb; 31(2):152-8. PubMed ID: 5545266
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemistry of drugs. XVI. Substances with antineoplastic effect. XXXVI. Absorption, tissue distribution and excretion of ethylester N--delta-(6--purinylthio) varleryl-glycylglycine-35S (Butodicine) in mice with Crocker's sarcoma 180.
    Ráz K; Francová V; Franc Z; Cerný A; Jelínek V; Semonský M
    Neoplasma; 1970; 17(1):37-42. PubMed ID: 5423432
    [No Abstract]   [Full Text] [Related]  

  • 6. ANTINEOPLASTIC DRUGS. VII. COMPARISON OF THE ABSORPTION, TISSUE DISTRIBUTION, AND EXCRETION OF 35S-BUTHIOPURIN AND ITS 35S-BUTYL ESTER IN S 180 SARCOMA-BEARING MICE.
    FRANCOVA V; RAZ K; FRANC Z; CERNY A; SEMONSKY M; JELINEK V
    Neoplasma; 1964; 11():165-70. PubMed ID: 14160696
    [No Abstract]   [Full Text] [Related]  

  • 7. Purinethiols as feedback inhibitors of purine synthesis in ascites tumor cells.
    LEPAGE GA; JONES M
    Cancer Res; 1961 Jun; 21():642-9. PubMed ID: 13760994
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic studies with carbocyclic analogs of purine nucleosides.
    Bennett LL; Allan PW; Hill DL
    Mol Pharmacol; 1968 May; 4(3):208-17. PubMed ID: 5661770
    [No Abstract]   [Full Text] [Related]  

  • 9. POTENTIAL PURINE ANTAGONISTS. XXXI. THE PREPARATION OF CERTAIN 9-ALKYL-2-AMINO-6-PURINETHIOLS AND RELATED DERIVATIVES AS ANTITUMOR AGENTS.
    NOELL CW; ROBINS RK
    J Med Pharm Chem; 1962 May; 5():558-88. PubMed ID: 14056392
    [No Abstract]   [Full Text] [Related]  

  • 10. [Compounds with antineoplastic effect. 26. Spectral and polarographic behavior of some substitured purines].
    Vachek J; Kakác B; Cerný A; Semonský M
    Pharmazie; 1968; 23(8):444-8. PubMed ID: 5715556
    [No Abstract]   [Full Text] [Related]  

  • 11. THE PRIMARY SITE OF INHIBITION BY 6-MERCAPTOPURINE ON THE PURINE BIOSYNTHETIC PATHWAY IN SOME TUMORS IN VIVO.
    BENNETT LL; SIMPSON L; GOLDEN J; BARKER TL
    Cancer Res; 1963 Oct; 23():1574-80. PubMed ID: 14072699
    [No Abstract]   [Full Text] [Related]  

  • 12. Nucleotide metabolism: mode of action of thiopurines in leukemia.
    De Abreu RA
    Adv Exp Med Biol; 1994; 370():195-200. PubMed ID: 7660889
    [No Abstract]   [Full Text] [Related]  

  • 13. The binding of the sulfur and oxygen purine derivatives with bovine serum albumin.
    Sochacka J; Sułkowska A; Kowalska A
    Acta Pol Pharm; 2008; 65(1):169-71. PubMed ID: 18536193
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential toxic effects of azathioprine, 6-mercaptopurine and 6-thioguanine on human hepatocytes.
    Petit E; Langouet S; Akhdar H; Nicolas-Nicolaz C; Guillouzo A; Morel F
    Toxicol In Vitro; 2008 Apr; 22(3):632-42. PubMed ID: 18222062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel derivatives of 6-mercaptopurine: synthesis, characterization and antiproliferative activities of S-allylthio-mercaptopurines.
    Miron T; Arditti F; Konstantinovski L; Rabinkov A; Mirelman D; Berrebi A; Wilchek M
    Eur J Med Chem; 2009 Feb; 44(2):541-50. PubMed ID: 18467007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.
    Al Hadithy AF; de Boer NK; Derijks LJ; Escher JC; Mulder CJ; Brouwers JR
    Dig Liver Dis; 2005 Apr; 37(4):282-97. PubMed ID: 15788214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [STUDIES ON ANTITUMOR DRUGS. III. THE USE OF IN VITRO CULTURE OF YOSHIDA ASCITES SARCOMA CELLS IN SCREENING ANTITUMOR SUBSTANCES].
    CHU TH; WU YI
    Yao Xue Xue Bao; 1963 Jun; 10():334-44. PubMed ID: 14070616
    [No Abstract]   [Full Text] [Related]  

  • 18. Impaired transport as a mechanism of resistance to thiopurines in human T-lymphoblastic leukemia cells.
    Fotoohi AK; Lindqvist M; Peterson C; Albertioni F
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1039-44. PubMed ID: 17065061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative kinetics of azathioprine and metazathioprine mercaptolysis in presence of physiological thiols.
    Chrzanowska M; Hałas A; Kuehn M; Hermann T
    Acta Pol Pharm; 2003; 60(4):269-73. PubMed ID: 14714854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity of the novel glutathione-activated thiopurine prodrugs cis-AVTP [cis-6-(2-acetylvinylthio)purine] and trans-AVTG [trans-6-(2-acetylvinylthio)guanine] results from the National Cancer Institute's anticancer drug screen.
    Gunnarsdottir S; Elfarra AA
    Drug Metab Dispos; 2004 Mar; 32(3):321-7. PubMed ID: 14977866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.